<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03052088</url>
  </required_header>
  <id_info>
    <org_study_id>MM-1006-AP</org_study_id>
    <nct_id>NCT03052088</nct_id>
  </id_info>
  <brief_title>Diagnostic Accuracy of a Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients</brief_title>
  <acronym>AutoPilot</acronym>
  <official_title>Multi-center, Prospective, Study to Validate the Accuracy and Assess the Clinical Utility of a Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MeMed Diagnostics Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Of Perugia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>MeMed Diagnostics Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective clinical validation study of a novel regulatory approved (CE-IVD)
      diagnostic assay called ImmunoXpert™ that will enroll 1222 pediatric patients. The study aims
      to externally validate the tool's diagnostic accuracy and estimate the potential improvement
      in health and economic outcomes following the usage of ImmunoXpert™. Additionally,
      statistical analysis will be performed to compare ImmunoXpert™ accuracy to current practice
      lab testing (e.g. WBC, CRP, and PCT) and clinical suspicion at time of requisition. Enrolled
      patients will be managed according to the current standard of care and per standard
      institutional procedures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 6, 2017</start_date>
  <completion_date type="Actual">August 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of the assay in differentiating between bacterial and viral etiologies of pediatric patients &gt;90 days old with suspicion of respiratory tract infection or fever without source.</measure>
    <time_frame>0-7 days after the initiation of symptoms</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of ANC, WBC, CRP, and PCT in differentiating between bacterial and viral etiologies of pediatric patients &gt;90 days old with suspicion of respiratory tract infection or fever without source.</measure>
    <time_frame>0-7 days after the initiation of symptoms</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1070</enrollment>
  <condition>Fever</condition>
  <condition>Respiratory Tract Infections</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible subjects from both genders that present to the ED due to suspected RTI, or FWS.
        Each of these patients falls into one of the following categories:

          1. Patients with an acute bacterial infection

          2. Patients with an acute viral infection

          3. Patients with an acute co-infection (bacterial and viral)

          4. Patients with an undetermined disease etiology
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Legal guardian signs an informed consent

          -  Documented peak temperature ≥ 38°C (100.4°F)

          -  Symptom duration ≤ 7 days

          -  Clinical suspicion of RTI (OR) fever without a clear source after clinical examination

        Exclusion Criteria:

          -  Another infection episode during the last 3 weeks before sampling

          -  Congenital immune deficiency (CID)

          -  A proven or suspected HIV, HBV, HCV infection

          -  Active hematological malignancy

          -  Current treatment with immune-suppressive or immune-modulating

          -  Other illnesses that affect life expectancy and/or quality of life
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tobias Tenenbaum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kinderklinik Universitatsmedizine mannheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kinderklinik Universitatsmedizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Perugia</name>
      <address>
        <city>Perugia</city>
        <zip>06129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Oved K, Cohen A, Boico O, Navon R, Friedman T, Etshtein L, Kriger O, Bamberger E, Fonar Y, Yacobov R, Wolchinsky R, Denkberg G, Dotan Y, Hochberg A, Reiter Y, Grupper M, Srugo I, Feigin P, Gorfine M, Chistyakov I, Dagan R, Klein A, Potasman I, Eden E. A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS One. 2015 Mar 18;10(3):e0120012. doi: 10.1371/journal.pone.0120012. eCollection 2015.</citation>
    <PMID>25785720</PMID>
  </reference>
  <reference>
    <citation>Eden E, Srugo I, Gottlieb T, Navon R, Boico O, Cohen A, Bamberger E, Klein A, Oved K. Diagnostic accuracy of a TRAIL, IP-10 and CRP combination for discriminating bacterial and viral etiologies at the Emergency Department. J Infect. 2016 Aug;73(2):177-80. doi: 10.1016/j.jinf.2016.05.002. Epub 2016 May 30.</citation>
    <PMID>27255416</PMID>
  </reference>
  <reference>
    <citation>van Houten CB, de Groot JAH, Klein A, Srugo I, Chistyakov I, de Waal W, Meijssen CB, Avis W, Wolfs TFW, Shachor-Meyouhas Y, Stein M, Sanders EAM, Bont LJ. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect Dis. 2017 Apr;17(4):431-440. doi: 10.1016/S1473-3099(16)30519-9. Epub 2016 Dec 22.</citation>
    <PMID>28012942</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>February 10, 2017</study_first_submitted>
  <study_first_submitted_qc>February 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2017</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

